Global Amniotic Membrane Market By Product (Cryopreserved and Dehydrated), By Application (Surgical Wounds, Ophthalmology and Other Applications), By End-Use ( Hospitals Ambulatory Surgical Centers (ASCs), Specialty Clinics and Research and Academic Institutes) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Amniotic Membrane Market Overview:

The amniotic membrane market size was worth USD 2,890 million by 2021. It is forecast to grow at a 14.4% compound annual growth rate (CAGR).

The amnion Membrane is widely used to heal wounds due to its bacteriostatic, pain reduction, and other properties.

In recent times, the demand for tissue-based products has increased due to an increase in transplants. This has led to an increase in the number and quality of donated tissue, which is fueling the market growth.

Amniotic cells are commonly used in a variety of indications, including the reconstruction of the conjunctiva’s surface, pterygium extractions, surgical wounds (corneal ulcers), pressure and venous leg injuries, and limbal stem cell deficiencies, and regenerative medicines.

The amniotic membrane market has been witnessing significant growth in recent years, owing to the increasing demand for amniotic products in the healthcare industry. The amniotic membrane market share is currently dominated by the United States, followed by Europe and Asia-Pacific regions. The amniotic membrane market trends suggest that the use of amniotic products is rapidly gaining popularity due to their regenerative properties, making them an ideal choice for wound healing and tissue repair applications.

Global Amniotic Membrane Market Scope

Product Analysis

Dehydrated and cryopreserved amniotic Membrane markets can be classified based on their product. Cryopreserved Amniotic Membrane accounted for the highest revenue share at more than 58.4% in 2021. Its high effectiveness and widespread adoption rate worldwide made it the most popular. This type of cryopreserved amniotic membrane is stored in a cell medium that contains 50% glucose at a temperature of -80 °C. The amniotic cell membrane is preserved in cryopreserved membranes. It retains its biological and histological characteristics.

The cryopreserved membranes have a major role in visual surgery. They are effective in reducing inflammation and improving recovery. This segment is expected to grow at a high growth rate in the future.

The treatment of many surgical wounds, such as reconstructions, and pressure leg ulcers, is usually done with dehydrated amniotic materials. These are typically used as biological bandages to encourage healing. Some examples of commercially-available dehydrated amniotic fluids include PalinGen (FloGraft), AmbioDisk (AmnioFix), and AmbioDisk (AmnioDisk). These membranes are popularly used to treat and manage surgical wounds. This is why dehydrated membranes are expected to increase in popularity.

Application Analysis

The market can be divided into three segments based on their application: ophthalmology and surgical wounds. In 2021, the surgical wounds segment was responsible for more than 37.2% of the total revenue.

The market potential has increased due to an increase in chronic and infectious diseases. These products are used most frequently in ophthalmic surgery to speed up recovery and decrease inflammation. These membranes can also be used in reconstructive surgery to promote healing and decrease scarring.

Amniotic membranes are a great way to reduce scarring, speed up healing and lower the risk of infection. These products are in high demand due to the increase in cosmetic surgery. This has greatly aided market growth. They are also used to reconstruct burns cases, which drives their demand. These cases are ideal for amniotic membranes because they facilitate epithelialization as well as rapid wound healing.

It has been shown to ease pain and facilitate movement of the affected areas. This method is more affordable than xenografts or allografts. It is becoming increasingly popular in developing countries, which will accelerate market growth.

End-Use Analysis

Market segments are based on end-use and include hospitals, Ambulatory Surgical Centers (ASCs), specialist clinics, and research institutes. In 2021 the hospital segment held the largest share, with 38.6% more. This is due to patients frequenting hospitals, which are the primary care settings that allow for quick treatment for a wide variety of illnesses.

The market is expected to grow due to the increased use of amniotic cells in ASCs. These products can be used quickly and effectively, and they also allow for faster wound healing. This allows for segment growth.

Key Market Segments

Product

• Cryopreserved
• Dehydrated

Application

• Surgical Wounds
• Ophthalmology
• Other Applications

End-Use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Research and Academic Institutes

Market Dynamics

Various factors are driving the amniotic membrane market growth, including the rising prevalence of chronic wounds and injuries, an increase in the number of surgical procedures, and the growing adoption of regenerative medicine. Moreover, advancements in the production of amniotic membrane products and their increasing applications in ophthalmology, orthopedics, and dermatology are also contributing to market expansion. Many amniotic membrane companies are investing in research and development activities to develop new and innovative products to meet the rising demand for amniotic products in the market.

Market growth is expected to be affected by increasing research in the field of stem cell and/or regenerative medicine, as well as heavy R&D investments and an increase in global surgeries.

The COVID-19 Pandemic has caused immense disruption in the supply chains of the entire medical devices industry. The operation of healthcare systems has been significantly altered by the COVID-19 pandemic. The pandemic caused disruptions across supply and demand chains, production capacities, sales, and revenue cycles, and resulted in economic activity being restricted.

Major market players are taking initiatives to overcome this pandemic. The market will grow rapidly over the forecast period thanks to innovative product development strategies, increased investments, partnerships, collaborations, and an increase in investment. There are two main uses for amniotic granules: as a surgical or biological graft. These membranes act as a scaffold and facilitate reepithelization when used as a graft.

Its anti-inflammatory and anti-scarring properties are especially important for burn injuries. This reduces pain and swelling. The market is expected to grow as people are more aware of the benefits.

Additionally, they can be used in treating eye surface diseases such as bacterial and bullous keratopathy, cataracts, bullous keratopathy corneal degenerations, ocular dystrophy, corneal tear, corneal keratopathy, corneal keratopathy, corneal keratopathy, corneal grafts, glaucoma, corneal keratopathy, corneal degenerations, glaucoma, corneal degenerations, eyelid reconstructions Globally, there has been an increase in the number of ophthalmology procedures. This has created a large demand for these tissue-based products.

Regional Analysis

North America dominated this market in 2021. It had accounted for the largest market share with 36.0%. Market growth in North America is due to strong healthcare infrastructure and the presence of major market players. This forecast period will see market growth continue to rise due to increased emphasis on alternative technologies as well as the adoption and promotion of advanced technologies.

Europe had the second-highest revenue share. The region is expected to grow at a steady rate from 2022 to 2032. The European region’s healthcare system, which is funded by the public, has seen a rise in product demand. Many countries have adopted universal healthcare systems. Healthcare professionals are expected to adopt amniotic skins more frequently as there is an increasing number of patients with chronic illnesses.

The WHO says that non-communicable illnesses, such as cancer, cardiovascular disease, chronic respiratory diseases, diabetes, kidney disease, and diabetes, account for 88% and 74%, respectively, of Europe’s deaths. A high number of chronic diseases and an increase in the surgical intervention are expected to drive market growth. The Asia Pacific is forecast to grow at a significant rate over the forecast period.

This region has many countries that are growing economically and have a steady increase in disposable income. This region is home to many multinational companies. It is anticipated that the growth of the market will be driven by the large unmet demand and the development of healthcare infrastructure, especially in India and Japan.

Кеу Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Companies & Market share Analysis:

There are many players in the market, both local and global. To ensure placental donation, the majority of market players have strong partnerships with hospitals and tissue banks. The American Association of Tissue Banks has accredited almost all of the market players to supply quality and sterile products.

The amniotic products market is highly competitive, with several players operating globally. Some of the prominent players in the market include Amnio Technology LLC, Skye Biologics Inc., IOP Ophthalmics, MiMedx Group Inc., and Osiris Therapeutics Inc. These companies are focusing on strategic collaborations and partnerships to expand their market presence and improve their product offerings. In conclusion, the amniotic membrane market is expected to witness substantial growth in the coming years, with increasing demand for amniotic products in the healthcare industry, along with the rising investments by amniotic membrane companies in product innovation and development.

Key Market Players:

• Alliqua BioMedical Inc.
• Amnio Technology, LLC
• Applied Biologics LLC
• Human Regenerative Technologies, LLC
• DermaSciences, Katena Products, Inc.
• MiMedx Group Inc.
• Skye Biologics, Inc.
• Other Key Players

For the Amniotic Membrane Market research study, the following years have been considered to estimate the market size: